Accretion Nutraveda Limited Share Price

Accretion Nutraveda Limited Share Price

BSE: 544694
|
Pharmaceuticals
₹ 274.00
+₹0.25 (0.09%)
1D
Last updated 23 Jul, 2026, 15:29 IST

--
0.09% up today
--
1D LOW
1D HIGH

Accretion Nutraveda Limited Returns Calculator


Circuit
L
H
₹260.10
₹287.40
52-week
L
H
₹150.10
₹300.00
Mkt Cap Cr
198.20

P/E
0.00

P/B
6.46

ROE
14.29%

D/E
0.12

ROCE
16.99%

Div. Yield
0.00%

EPS(TTM)
9.35
Turnover
0.86

EV/EBITDA
0.00

Net Margin
0.00%

Op. Margin
0.00%

ROA
0.00%

Quick Ratio
0.00

Curr. Ratio
17.31
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Accretion Nutraveda outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Accretion Nutraveda appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories97,364.9030.582.5611.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

Accretion Nutraveda Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹16.00₹5.01₹2.90
Other Income₹0.05₹0.19₹0.17
Total Revenue₹16.06₹5.20₹3.07
Total Expenses₹12.87₹4.28₹2.78
Profit Before Tax₹3.18₹0.91₹0.29
Tax₹0.57₹0.09₹0.01
Profit After Tax₹2.61₹0.82₹0.28
EPS - Basic₹71.91₹22.83₹7.79
EPS - Diluted₹71.91₹22.83₹7.79

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹3.18₹0.91₹0.29
Income before WC changes₹3.78₹1.42₹0.79
Change in Assets-₹5.70-₹0.65-₹1.20
Change in Liabilities₹0.26-₹0.44₹1.09
Change in WC-₹5.44-₹1.08-₹0.11
Cash flow from Operations-₹2.21₹0.23₹0.68
Cash flow from Investing-₹0.87-₹0.16-₹0.01
Cash flow from Financing₹2.98-₹0.04-₹0.63
Total Cash Flow-₹0.10₹0.03₹0.04
Cash (Start of the year)₹0.12₹0.09₹0.04
Cash (End of the year)₹0.02₹0.12₹0.09

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹2.02₹1.39₹1.49
Current Assets₹8.85₹3.25₹2.57
Total Assets₹10.86₹4.64₹4.06
Current Liabilities₹3.95₹3.03₹2.41
Net Current Asset₹4.89₹0.22₹0.16
Non-Current Liabilities₹1.56₹0.52₹1.39
Equity Capital₹5.35₹1.08₹0.26
Total Equity & Liabilities₹10.86₹4.64₹4.06
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
57.35
Neutral

ATR (14)
8
Neutral

STOCH(9,6)
86.29
Bearish

STOCH RSI (14)
81.56
Bearish

ADX(9)
15.84
Bullish

UO(9)
78.76
Bearish

ROC(12)
5.29
Bullish

WillR(14)
-13.71
Bearish
Period
Simple value
Exponential vaue

5D
272.15
271.46

10D
265.7
267.73

20D
262.7
264

50D
256.73
262.42

100D
226.82
0

About Accretion Nutraveda Limited

Accretion Nutraveda Limited Share Price
ISIN
INE1KVQ01019
Sector Market Cap
₹ 198.2 Cr

Accretion Nutraveda Limited Financial Highlights

  • Revenue: Accretion Nutraveda Limited reported revenue of ₹33.71 crore in FY26 vs ₹16.01 crore in FY25. It showed an increase of 110.56% on a yearly basis.
  • Operating Profit: Accretion Nutraveda Limited reported an operating profit of ₹6.21 crore in FY26 vs ₹3.15 crore in FY25. It showed an increase of 97.14% on a year-on-year basis.
  • Net Profit: Accretion Nutraveda Limited reported a net profit of ₹5.07 crore in FY26 vs ₹2.50 crore in FY25. It showed an increase of 102.80% on a yearly basis.
Know more
Promoters
73.48%
FII
1.08%
Other DII
6.11%
Retail and other
19.34%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Accretion Nutraveda Limited Share Price
Accretion Nutraveda Limited
Pharmaceuticals
Add Stock
Add Another

FAQs on Accretion Nutraveda Limited Share Price